Cyproheptadine
In Stock•Starting at $185 for 5 mg•Purity ≥ 99.92%
| CAS No. | 129-03-3 |
|---|---|
| MDL No. | N/A |
| MF | C21H21N |
| MW | 287.40 |
| InChI Key | JJCFRYNCJDLXIK-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | 99.92% ; | $185 | In Stock | |
| 10 mg | 99.92% ; | $298 | In Stock | |
| 25 mg | 99.92% ; | $547 | In Stock | |
| 50 mg | 99.92% ; | $794 | In Stock | |
| 100 mg | 99.92% ; | $1180 | In Stock |
Product Information
Cyproheptadine is formed by the oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine, creating a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking properties. Used primarily as the hydrochloride sesquihydrate, it treats allergic conditions such as rhinitis, conjunctivitis, urticaria, angioedema, and pruritic skin disorders. Unlike other antihistamines, it also acts as a serotonin receptor antagonist, making it effective for vascular headaches and anorexia. It functions as a H1-receptor antagonist, serotonergic antagonist, antipruritic, anti-allergic, and gastrointestinal drug. It belongs to the piperidine class and is a tertiary amine.
| CAS No. | 129-03-3 |
|---|---|
| Product Name | Cyproheptadine |
Biological Targets
HRH1
Associated Conditions
cancer·COVID-19·Abdominal pain·allergic disease·urticaria·
* The information provided here is compiled from public sources and is for reference only.
